---
title: "Amazon, Pfizer, Eaton And A Financial Stock On CNBC’s ‘Final Trades’"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304269097.md"
description: "On CNBC’s 'Final Trades,' Joshua Brown selected Amazon despite missed Q3 earnings; Jim Lebenthal chose BlackRock following strong results; Jason Snipe picked Eaton after it raised guidance and beat estimates; and Joseph Terranova recommended Pfizer, which also reported upbeat Q3 sales and earnings. Stock prices varied: Amazon rose 2.1%, BlackRock fell 0.5%, Eaton surged 7%, and Pfizer dropped 2.2%."
datetime: "2026-11-04T11:37:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304269097.md)
  - [en](https://longbridge.com/en/news/304269097.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304269097.md)
generator: "portal-rs"
---

# Amazon, Pfizer, Eaton And A Financial Stock On CNBC’s ‘Final Trades’

On CNBC’s “Halftime Report Final Trades,” **Joshua Brown**, co-founder and CEO of Ritholtz Wealth Management, picked **Amazon.com, Inc.** (NASDAQ:AMZN).

On the earnings front, Amazon reported worse-than-expected third-quarter results on Oct. 29. Amazon posted third-quarter revenue of $201.94 billion, missing the consensus estimate of $202.31 billion, according to Benzinga Pro. The company reported earnings of $1.89 per share for the quarter, missing estimates of $1.97 per share.

**Jim Lebenthal**, partner and chief market strategist at Cerity Partners, said **BlackRock, Inc.** (NYSE:BLK) is ready to break out.

Lending support to his choice, BlackRock reported better-than-expected third-quarter financial results on Oct. 14.

*Don’t forget to check out our premarket coverage here*

**Jason Snipe**, founder and chief investment officer of Odyssey Capital Advisors, named **Eaton Corporation plc** (NYSE:ETN) as his final trade.

Supporting his view, Eaton, on Tuesday, reported upbeat third-quarter financial results, raised its FY26 earnings guidance and issued fourth-quarter EPS guidance with its midpoint above estimates.

**Joseph M. Terranova**, senior managing director for Virtus Investment Partners, recommended **Pfizer Inc.** (NYSE:PFE).

Pfizer reported upbeat third-quarter results on Tuesday. The company posted third-quarter sales of $16.58 billion, beating the consensus of $15.87 billion. Pfizer’s adjusted earnings came in at 87 cents per share, beating the consensus of 72 cents.

## **Price Action**

-   Amazon shares gained 2.1% to close at $250.69 on Tuesday.
-   BlackRock shares declined 0.5% to close at $1,161.32.
-   Eaton shares rose 7% to settle at $391.70 on Tuesday.
-   Pfizer shares fell 2.2% to settle at $30.00 during the session.

 **See More: Top Value Stocks** 

*Photo via Shutterstock*

### Related Stocks

- [AMZN.US](https://longbridge.com/en/quote/AMZN.US.md)
- [BLK.US](https://longbridge.com/en/quote/BLK.US.md)
- [ETN.US](https://longbridge.com/en/quote/ETN.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [AMAA.US](https://longbridge.com/en/quote/AMAA.US.md)
- [AMZD.US](https://longbridge.com/en/quote/AMZD.US.md)
- [AMZG.US](https://longbridge.com/en/quote/AMZG.US.md)
- [AMZO.US](https://longbridge.com/en/quote/AMZO.US.md)
- [AMZP.US](https://longbridge.com/en/quote/AMZP.US.md)
- [AMZU.US](https://longbridge.com/en/quote/AMZU.US.md)
- [AMZW.US](https://longbridge.com/en/quote/AMZW.US.md)
- [AMZY.US](https://longbridge.com/en/quote/AMZY.US.md)
- [AMZZ.US](https://longbridge.com/en/quote/AMZZ.US.md)
- [AZYY.US](https://longbridge.com/en/quote/AZYY.US.md)

## Related News & Research

- [Amazon.com, Inc. $AMZN Stake Decreased by Bank Pictet & Cie Europe AG](https://longbridge.com/en/news/303935602.md)
- [Why Amazon Stock Can Keep Rising Through 2035](https://longbridge.com/en/news/304134700.md)
- [14,268 Eaton Corporation, PLC $ETN Shares Sold by Bank Julius Baer & Co. Ltd Zurich](https://longbridge.com/en/news/303939858.md)
- [Eaton sales up 28%; GAAP EPS rises just 7%: Rapid earnings reaction](https://longbridge.com/en/news/304142404.md)
- [What's Going On With Eaton Shares On Wednesday?](https://longbridge.com/en/news/304321362.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**